CBD Info, CBD News

Hemp and COVID-19

CBD helps against COVID-19

CBD can be used in several ways. Applicable in oil, cream, conditioner, vaporizer oil, pills, and food. 

You can use the oil on its own, and you usually put it under your tongue. The oil can also be packed into capsules and taken this way if you don’t think you can take it orally.

The better you grow, the better for you and your family. You never want to add anything covered in pesticides to your regimen. Also, you need to know where your CBD comes from, such as location. 

You want to make sure that you don’t get a cut version of the CBD oil extracted from your marijuana plant along with butane and grown in your basement. This is not the safest way to get your CBD.

As the global number of coronavirus deaths has risen dramatically, the Lancet has drawn attention to the “accumulating evidence” indicating that “patients with severe Covid-19 virus may have cytokine syndrome.”

This incomprehensible syndrome is characterized by a severe overreaction of the lungs’ immune system and can make people sick and kill those who suffer from it. Shortness of breath is the leading cause of death in COVID-19 cases.

Science Daily reports that a highly inflammatory cell storm, in which a wave of immune cells became corrupted, was likely the leading cause of death in several virus outbreaks, including the 1918-1919 pandemic (which killed more than 50 million people) and recently the timing of the H1N1 swine flu (AKA) “bird flu”.

In cases of acute lung disease caused by viruses, targeted therapy for cytokine storms appears beneficial. However, corticosteroid treatment is not a good option because it can worsen the lung infection associated with COVID-19. However, the Lancet notes that “immunosuppression is likely to help cases of excessive inflammation.”

Can hemp calm a cell storm?

The short answer is that we don’t know. We still don’t understand much about CBD and COVID-19. Federal control over hemp research is the main reason we know so little about CBD’s clinical potential as an antiviral agent.

The hemp ban is exacerbating the current crisis in other ways as well, as we’ll see later in this article. Now let’s go back to cytokines and hemp.

What are cytokines?

A cytokine known as tumor necrosis factor-alpha (TNFa) is overproduced in rheumatoid arthritis, a painful autoimmune disease that affects 1.3 million Americans. How does CBD benefits our immune system against viral infections?

Could CBD be a suitable candidate for reducing deaths in critically ill COVID-19 patients? A few dozen websites have already advertised that CBD has anti-virus uses as if it were established medical facts.

According to a team of British and Italian scientists who recently researched the online journal Cannabis and Cannabinoid Research topic, there is so far only “fragmented evidence” indicating the “potential use of CBD Oil for viral infection.” 

The authors pointed to an in vitro study that indicated that CBD has direct antiviral effects against the hepatitis C virus. Apart from preclinical research with hepatitis C, there is little scientific evidence to support CBD’s purported antiviral properties.

The authors cited another study that found that CBD benefits our immune system by reducing nerve inflammation in an animal model caused by multiple sclerosis. However, they admit that this may have more to do with CBD’s effectiveness as an anti-inflammatory compound than its direct antiviral activity.

CBD is currently in clinical trials in Israel to treat graft-versus-host disease (GVHD), a life-threatening illness (with a mortality rate of more than 80 percent) caused by the immune system’s rejection of an organ or bone marrow transplant. So far, the results have been encouraging. 

Deaths from GVHD and COVID-19 are associated with a severe immune overreaction, but there is one crucial difference: a virus does not cause GVHD. CBD has never been tested as a treatment for a cytotoxic storm caused by the virus.

Data collision

Many of the therapeutic uses of CBD and THC are related to their anti-inflammatory effects. But this is not the whole story. The interaction between cannabis and the immune system is complex, adaptive, and bidirectional.

In some cases, hemp can stimulate immune activity. A 2014 study by scientists at Louisiana State University showed that regular cannabis use could increase the white blood cell count in immunodeficiency disorders such as HIV, indicating an inflammatory and immune-stimulating effect. 

This is the exact opposite of what is needed to mitigate a virus-induced cell storm.

Given the conflicting data on the effect of cannabinoids on immune function, medical professionals are re-evaluating their ideas about inflammation and immunosuppression. 

Mary Bills reported to the CBD Oil Project: “A new wave of research and more anecdotal evidence indicates that cannabis has an adaptive immune effect, not just by inhibiting immune activity.”

Cannabis’s ability to suppress and enhance immune function confirms the belief that the endocannabinoid system is involved in a bidirectional immune modulation that keeps inflammation under control under healthy conditions and allows the inflammatory response to fight infection necessary.

Dr. Garcia de Palau, the Spanish cannabis doctor, summed it up: “I think [cannabis] is an immunosuppressant when there is an excessive immune response, but otherwise it regulates and corrects the immune system. It can even be said that it works like the endocannabinoid system. and brings balance to the body “.

A call to solidarity

Cannabidiol or cannabis as a preventive measure help make us more vulnerable to coronavirus infection? A relatively small percentage of people infected with COVID-19 experience a life-threatening cell storm. However, if someone is infected (showing no severe symptoms), can CBD Oil increase the risk of developing the disease? Will CBD have an impact?

The International Association for Cannabis Medicines (IACM), based in Germany, issued a statement on the COVID-19 epidemic and cannabis use, noting that some laboratory studies indicate that cannabis may have antiviral effects. 

However, according to the IACM, “there is no evidence that individual cannabinoids, such as CBD, CBG or THC, or hemp preparations protect against infection … or are used to treat COVID-19 because the CBD promotes immunity.

However, the IACM also emphasizes, “There is no evidence that cannabis use can increase the risk of developing a viral infection.”

The CBD immunity Project, a US ambassador to the IACM, supports the association’s call for “solidarity at this time, especially with those particularly threatened by such infection.” The IACM urges not to share “misinformation spread over the Internet.” 

“Help contain the spread of the virus by following government and health agency guidelines.”

It has been reported that people who stock hemp products from licensed pharmacies and delivery services in the United States, where the use of cannabis is considered for medicinal and adult purposes. 

Many state governments have followed California’s footsteps, pointing out that CBD immunity businesses are essential services that can remain open. In contrast, the pandemic has led to shutdowns and shutdowns in the hardest-hit areas.

But cannabis is still illegal under federal law, and cannabis prohibition is making the situation worse. The pandemic has increased the damage caused by US drug policy, which continues to hamper scientific research and impede medical progress by blocking curative cannabis research. 

As a result, we don’t have clear answers to the main questions about cannabis and viral infections in times of urgent need.

COVID-19 and the prohibition of CBD

The hemp ban also poses unnecessary risks to public health in other regions. 

Due to the facility’s criminal status at the federal level, banks are prohibited from opening accounts and issuing credit cards to cannabis companies. Even legitimate government-licensed businesses are forced to operate on cash alone. 

This practice puts frontline pharmaceutical workers, other industrial workers, and government tax collectors at risk. Dealing with cash can be dangerous during a pandemic.

According to the New England Journal of Medicine, the coronavirus is “stable in aerosols and on surfaces for hours or days.” This includes paper money and coins, says Dr. Sanjay Maguire, chair of the Department of Microbiology, Immunology and Tropical Medicine at the George Washington University School of Medicine. 

“With the coronavirus, money management is definitely a problem,” he told CBS MoneyWatch.

As with the limitations of the investigation, this practice is entirely unnecessary and can easily be remedied by Congress’s expedited legislative action.

Related Posts